BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 23014264)

  • 1. Management of optic neuritis as a clinically first event of multiple sclerosis.
    Kale N
    Curr Opin Ophthalmol; 2012 Nov; 23(6):472-6. PubMed ID: 23014264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evolving management of optic neuritis and multiple sclerosis.
    Arnold AC
    Am J Ophthalmol; 2005 Jun; 139(6):1101-8. PubMed ID: 15953446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute inflammatory demyelinating optic neuritis: evidence-based visual and neurological considerations.
    Abou Zeid N; Bhatti MT
    Neurologist; 2008 Jul; 14(4):207-23. PubMed ID: 18617847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple sclerosis and the ophthalmologist.
    Mowry EM; Balcer LJ; Galetta SL
    Compr Ophthalmol Update; 2007; 8(1):39-49. PubMed ID: 17394758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Should patients with optic neuritis be treated with steroids?
    Mackay DD
    Curr Opin Ophthalmol; 2015 Nov; 26(6):439-44. PubMed ID: 26367086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optic neuritis in multiple sclerosis.
    Chan JW
    Ocul Immunol Inflamm; 2002 Sep; 10(3):161-86. PubMed ID: 12789593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of optic neuritis in Ireland: a survey comparing the management practices of acute demyelinating optic neuritis amongst ophthalmologists and neurologists in Ireland.
    Kobayter L; Chetty S
    Ir J Med Sci; 2019 Feb; 188(1):277-282. PubMed ID: 29693233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High- and low-risk profiles for the development of multiple sclerosis within 10 years after optic neuritis: experience of the optic neuritis treatment trial.
    Beck RW; Trobe JD; Moke PS; Gal RL; Xing D; Bhatti MT; Brodsky MC; Buckley EG; Chrousos GA; Corbett J; Eggenberger E; Goodwin JA; Katz B; Kaufman DI; Keltner JL; Kupersmith MJ; Miller NR; Nazarian S; Orengo-Nania S; Savino PJ; Shults WT; Smith CH; Wall M;
    Arch Ophthalmol; 2003 Jul; 121(7):944-9. PubMed ID: 12860795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of optic neuritis and multiple sclerosis.
    Van Stavern GP
    Curr Opin Ophthalmol; 2001 Dec; 12(6):400-7. PubMed ID: 11734679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Steroids for multiple sclerosis and optic neuritis: a meta-analysis of randomized controlled clinical trials.
    Brusaferri F; Candelise L
    J Neurol; 2000 Jun; 247(6):435-42. PubMed ID: 10929272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multifocal visual evoked potential analysis of inflammatory or demyelinating optic neuritis.
    Fraser CL; Klistorner A; Graham SL; Garrick R; Billson FA; Grigg JR
    Ophthalmology; 2006 Feb; 113(2):323.e1-323.e2. PubMed ID: 16406544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pediatric optic neuritis: brain MRI abnormalities and risk of multiple sclerosis.
    Bonhomme GR; Waldman AT; Balcer LJ; Daniels AB; Tennekoon GI; Forman S; Galetta SL; Liu GT
    Neurology; 2009 Mar; 72(10):881-5. PubMed ID: 19273821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Corticosteroids in the treatment of multiple sclerosis and optic neuritis].
    Elovaara I; Pirttilä T
    Duodecim; 2000; 116(15):1547-54. PubMed ID: 12001474
    [No Abstract]   [Full Text] [Related]  

  • 14. The effect of corticosteroids for acute optic neuritis on the subsequent development of multiple sclerosis. The Optic Neuritis Study Group.
    Beck RW; Cleary PA; Trobe JD; Kaufman DI; Kupersmith MJ; Paty DW; Brown CH
    N Engl J Med; 1993 Dec; 329(24):1764-9. PubMed ID: 8232485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of multiple sclerosis in a child presenting with acute bilateral retrobulbar optic neuritis.
    Imaizumi M; Ogata N; Arichi M
    Jpn J Ophthalmol; 2004; 48(2):177-9. PubMed ID: 15060802
    [No Abstract]   [Full Text] [Related]  

  • 16. Acute inflammatory demyelinating optic neuritis: current concepts in diagnosis and management.
    Bhatti MT; Schmitt NJ; Beatty RL
    Optometry; 2005 Sep; 76(9):526-35. PubMed ID: 16198993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optic neuritis and risk of MS: differential diagnosis and management.
    Osborne BJ; Volpe NJ
    Cleve Clin J Med; 2009 Mar; 76(3):181-90. PubMed ID: 19258465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple sclerosis on steroids.
    Johnson MS; Lee MS; Younge BR; Purvin V
    Surv Ophthalmol; 2010; 55(5):460-6. PubMed ID: 20347108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Erythropoietin for acute multiple sclerosis in patients with optic neuritis as a first demyelination event.
    Borhani-Haghighi A; Ghodsi M; Razeghinejad MR; Mardani S; Mardani M; Nikseresht AR; Safari A; Bagheri MH
    Neurosciences (Riyadh); 2012 Apr; 17(2):151-5. PubMed ID: 22465890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute demyelinating optic neuritis.
    Foroozan R; Buono LM; Savino PJ; Sergott RC
    Curr Opin Ophthalmol; 2002 Dec; 13(6):375-80. PubMed ID: 12441840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.